410 related articles for article (PubMed ID: 25461771)
1. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
Ngeow J; Eng C
Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
[TBL] [Abstract][Full Text] [Related]
2. PTEN in Hereditary and Sporadic Cancer.
Ngeow J; Eng C
Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31570378
[TBL] [Abstract][Full Text] [Related]
3. Germline PTEN Mutation Analysis for PTEN Hamartoma Tumor Syndrome.
Ngeow J; Eng C
Methods Mol Biol; 2016; 1388():63-73. PubMed ID: 27033071
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
5. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
Bennett KL; Mester J; Eng C
JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
[TBL] [Abstract][Full Text] [Related]
6. Cowden syndrome.
Gustafson S; Zbuk KM; Scacheri C; Eng C
Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
[TBL] [Abstract][Full Text] [Related]
7. Cowden syndrome: report of two cases with immunohistochemical analysis for PTEN expression.
Zabetian S; Mehregan D
Am J Dermatopathol; 2012 Aug; 34(6):632-4. PubMed ID: 22481496
[TBL] [Abstract][Full Text] [Related]
8. [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
Longy M
Bull Cancer; 2001 Dec; 88(12):1153-8. PubMed ID: 11792608
[TBL] [Abstract][Full Text] [Related]
9. Detecting Germline PTEN Mutations Among At-Risk Patients With Cancer: An Age- and Sex-Specific Cost-Effectiveness Analysis.
Ngeow J; Liu C; Zhou K; Frick KD; Matchar DB; Eng C
J Clin Oncol; 2015 Aug; 33(23):2537-44. PubMed ID: 26169622
[TBL] [Abstract][Full Text] [Related]
10. PTEN hamartoma tumor syndrome.
Mester J; Charis E
Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
[TBL] [Abstract][Full Text] [Related]
11. PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers.
Won HS; Chang ED; Na SJ; Whang IY; Lee DS; You SH; Kim YS; Kim JS
Cancer Res Treat; 2019 Jan; 51(1):402-407. PubMed ID: 29510612
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
[TBL] [Abstract][Full Text] [Related]
13. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
14. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
Pilarski R; Burt R; Kohlman W; Pho L; Shannon KM; Swisher E
J Natl Cancer Inst; 2013 Nov; 105(21):1607-16. PubMed ID: 24136893
[TBL] [Abstract][Full Text] [Related]
15. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
[TBL] [Abstract][Full Text] [Related]
16. Clinical Implications for Germline PTEN Spectrum Disorders.
Ngeow J; Sesock K; Eng C
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
[TBL] [Abstract][Full Text] [Related]
17. PTEN: one gene, many syndromes.
Eng C
Hum Mutat; 2003 Sep; 22(3):183-98. PubMed ID: 12938083
[TBL] [Abstract][Full Text] [Related]
18. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.
Lee YR; Yehia L; Kishikawa T; Ni Y; Leach B; Zhang J; Panch N; Liu J; Wei W; Eng C; Pandolfi PP
N Engl J Med; 2020 May; 382(22):2103-2116. PubMed ID: 32459922
[TBL] [Abstract][Full Text] [Related]
19. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.
Orloff MS; Eng C
Oncogene; 2008 Sep; 27(41):5387-97. PubMed ID: 18794875
[TBL] [Abstract][Full Text] [Related]
20. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
